Cetrelimab (Anti-PDCD1 / PD-1 / CD279)
Cetrelimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting programmed cell death 1 (PD-1). It inhibits tumor growth in vivo. MW :145.04 KD.
| Trivial name | JNJ 63723283 |
| Catalog Number | A3029 |
| CAS# | 2050478-92-5 |
| Size | 1mg |